INTEGRA LIFESCIENCES HOLDINGS CORP
IART · Surgical & Medical Instruments & Apparatus · 77.8M shares · -2%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: $255M (gross $275M, SBC $20M)
Reference price $11.35 · est. market cap ~$883M — last insider purchase, 2025-11-05 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Surgical/regenerative-device maker with operating losses and cash burn (recall/charge-driven).
Strengths
- High gross margin — 51%
- Adequate liquidity — current ratio 2.5 (45th)
Risks
- Operating/net losses — operating margin -30%, ROE -49%
- Cash burn — FCF -$31M
- Recall/quality and integration issues — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Cash burnNegative free cash flow (-31.1M)
- Customer concentration~70% of revenue from one customer/distributor — The CSS segment, which represents approximately 70% of our total revenue, consists of market-leading technologies and instrumentation used for a wide range of specialties, such as neurosurgery, neuroc
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC
- Net lossNet loss (net margin -31.6%)
- Strong balance sheetStrong balance sheet — $264M cash & investments, ~34 quarters of runway
- Notable holderHeld by 4 notable fund(s): STATE STREET CORP, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC +1 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
50.9%
Operating margin
-30.2%
Net margin
-31.6%
Return on equity
-49.5%
Return on assets
-14.3%
ROIC
-22.0%
Revenue growth (QoQ)
-9.9%
Debt / equity
0.7×
Current ratio
2.5×
Free cash flow
-$31M
Tangible book value
-$706M
Cash & investments
$264M
Cash runway
34q
Stock comp / revenue
1.1%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-09 | BRADLEY KEITH | Tax withheld | 882 | $13.92 |
| 2026-05-07 | HILL BARBARA B | Grant | 6.6K | — |
| 2026-05-07 | HILL BARBARA B | Grant | 18K | — |
| 2026-03-11 | DAVIS ROBERT T. JR. | Tax withheld | 8.5K | $9.61 |
| 2026-03-11 | Veillon-Berteloot Chantal | Tax withheld | 5.4K | $9.61 |
| 2026-03-11 | Knight Lea Daniels | Tax withheld | 8.1K | $9.61 |
| 2026-03-11 | Singh Harvinder | Tax withheld | 861 | $9.61 |
| 2026-03-11 | Singh Harvinder | Option exercise | 19K | — |
| 2026-03-11 | Singh Harvinder | Tax withheld | 5.2K | $9.61 |
| 2026-03-11 | McBreen Michael J. | Tax withheld | 7.2K | $9.61 |
| 2026-03-11 | Mosebrook Jeffrey | Tax withheld | 806 | $9.61 |
| 2026-03-10 | Singh Harvinder | Tax withheld | 601 | $9.55 |
| 2026-03-10 | Mosebrook Jeffrey | Tax withheld | 341 | $9.55 |
| 2026-03-10 | McBreen Michael J. | Tax withheld | 2.4K | $9.55 |
| 2026-03-10 | DAVIS ROBERT T. JR. | Tax withheld | 687 | $9.55 |
| 2026-03-10 | Singh Harvinder | Option exercise | 1.2K | — |
| 2026-01-06 | Poul Mojdeh | Option exercise | 848 | — |
| 2026-01-06 | Poul Mojdeh | Option exercise | 542 | — |
| 2026-01-06 | Poul Mojdeh | Tax withheld | 848 | $13.13 |
| 2026-01-06 | Poul Mojdeh | Tax withheld | 542 | $13.13 |
| 2025-11-05 | GRAVES JEFFREY A | Buy | 9.0K | $11.35 |
| 2025-10-12 | Singh Harvinder | Tax withheld | 3.3K | $13.34 |
| 2025-10-12 | Singh Harvinder | Option exercise | 12K | — |
| 2025-09-01 | Veillon-Berteloot Chantal | Tax withheld | 2.1K | $15.13 |
| 2025-09-01 | Veillon-Berteloot Chantal | Tax withheld | 1.4K | $15.13 |
| 2025-08-14 | ESSIG STUART | Other | 200K | $13.62 |
| 2025-08-14 | ESSIG STUART | Other | 200K | $13.62 |
| 2025-07-03 | Mosebrook Jeffrey | Tax withheld | 3.3K | $13.49 |
| 2025-07-03 | Knight Lea Daniels | Tax withheld | 2.6K | $13.49 |
| 2025-07-01 | Mosebrook Jeffrey | Tax withheld | 937 | $13.25 |
| 2025-05-09 | Clay Shaundra | Grant | 20K | — |
| 2025-05-09 | BRADLEY KEITH | Tax withheld | 392 | $12.25 |
| 2025-05-09 | BRADLEY KEITH | Grant | 20K | — |
| 2025-05-09 | GRAVES JEFFREY A | Grant | 20K | — |
| 2025-05-09 | HILL BARBARA B | Grant | 6.9K | — |
| 2025-05-09 | HILL BARBARA B | Grant | 20K | — |
| 2025-05-09 | Lo Renee Wonlai | Grant | 20K | — |
| 2025-05-09 | SCHADE CHRISTIAN S | Grant | 6.9K | — |
| 2025-05-09 | SCHADE CHRISTIAN S | Grant | 20K | — |
| 2025-05-09 | ESSIG STUART | Grant | 6.9K | — |
| 2025-05-09 | ESSIG STUART | Grant | 25K | — |
| 2025-03-11 | Schwartz Eric | Tax withheld | 1.5K | $23.95 |
| 2025-03-11 | Schwartz Eric | Tax withheld | 1.2K | $23.95 |
| 2025-03-11 | Knight Lea Daniels | Tax withheld | 1.7K | $23.95 |
| 2025-03-11 | Knight Lea Daniels | Grant | 21K | — |
| 2025-03-11 | Mosebrook Jeffrey | Tax withheld | 134 | $23.95 |
| 2025-03-11 | Mosebrook Jeffrey | Tax withheld | 309 | $23.95 |
| 2025-03-11 | Mosebrook Jeffrey | Grant | 5.5K | — |
| 2025-03-11 | McBreen Michael J. | Tax withheld | 446 | $23.95 |
| 2025-03-11 | McBreen Michael J. | Tax withheld | 1.6K | $23.95 |
| 2025-03-11 | McBreen Michael J. | Grant | 18K | — |
| 2025-03-11 | Veillon-Berteloot Chantal | Tax withheld | 524 | $23.95 |
| 2025-03-11 | Veillon-Berteloot Chantal | Grant | 7.3K | — |
| 2025-03-11 | DAVIS ROBERT T. JR. | Tax withheld | 472 | $23.95 |
| 2025-03-11 | DAVIS ROBERT T. JR. | Tax withheld | 907 | $23.95 |
| 2025-03-11 | DAVIS ROBERT T. JR. | Grant | 12K | — |
| 2025-03-11 | Singh Harvinder | Option exercise | 2.4K | — |
| 2025-03-11 | Singh Harvinder | Tax withheld | 647 | $23.95 |
| 2025-03-11 | Singh Harvinder | Grant | 9.5K | — |
| 2025-03-10 | Mosebrook Jeffrey | Tax withheld | 111 | $22.61 |
| 2025-03-10 | Mosebrook Jeffrey | Tax withheld | 166 | $22.61 |
| 2025-03-10 | McBreen Michael J. | Tax withheld | 1.2K | $22.61 |
| 2025-03-10 | McBreen Michael J. | Tax withheld | 1.1K | $22.61 |
| 2025-03-10 | Schwartz Eric | Tax withheld | 773 | $22.61 |
| 2025-03-10 | DAVIS ROBERT T. JR. | Tax withheld | 592 | $22.61 |
| 2025-03-10 | Singh Harvinder | Option exercise | 1.2K | — |
| 2025-03-10 | Singh Harvinder | Tax withheld | 324 | $22.61 |
All non-derivative Form 4 activity (SEC), newest first.
Supply chain
Customers (0)
Suppliers (1)
- SM USA, Inc.
Named in the 10-K; linked when we track them.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-08 | Exec/director changeShareholder voteExhibits | filing ↗ |
| 2026-05-05 | Exec/director changeExhibits | filing ↗ |
| 2026-05-05 | ResultsExhibits | filing ↗ |
| 2026-04-15 | Material agreement | filing ↗ |
| 2026-02-26 | ResultsExhibits | filing ↗ |
| 2025-12-12 | Exec/director changeExhibits | filing ↗ |
| 2025-10-30 | ResultsExhibits | filing ↗ |
| 2025-07-31 | ResultsExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-08 | 2026-05-07 | 0000917520-26-000044 ↗ |
| 8-K | 2026-05-05 | 2026-05-05 | 0000917520-26-000033 ↗ |
| 8-K | 2026-05-05 | 2026-04-30 | 0000917520-26-000034 ↗ |
| 10-Q | 2026-05-05 | 2026-03-31 | 0000917520-26-000041 ↗ |
| 8-K | 2026-04-15 | 2026-04-10 | 0000917520-26-000019 ↗ |
| 8-K | 2026-02-26 | 2026-02-26 | 0000917520-26-000008 ↗ |
| 10-K | 2026-02-26 | 2025-12-31 | 0000917520-26-000011 ↗ |
| 8-K | 2025-12-12 | 2025-12-11 | 0000917520-25-000100 ↗ |
| 8-K | 2025-10-30 | 2025-10-30 | 0000917520-25-000094 ↗ |
| 10-Q | 2025-10-30 | 2025-09-30 | 0000917520-25-000096 ↗ |
| 10-Q | 2025-07-31 | 2025-06-30 | 0000917520-25-000074 ↗ |
| 8-K | 2025-07-31 | 2025-07-31 | 0000917520-25-000069 ↗ |